banner
home azienda prodotti anatomia contatti
integratori
ombra_sx
red_line
down
icon
More info  

Glaucoma is one of the main causes of blindness in the world and is an insidious illness, which in the majority of cases develops slowly without the patient being aware that their vision is deteriorating. Approximately two million Americans are affected by this disease, but approximately half of them ignore it. In Italy, glaucoma has an incidence of approximately 30%. Treatment of glaucoma seeks to lower intraocular pressure to a level which does not cause further damage to the optic nerve using two different mechanisms: reducing the production of aqueous humour and easing its discharge. In any case, they manage to keep eye pressure within normal limits thus avoiding damage to the optic nerve. Their effect only lasts for as long as they are taken however and that is why, once started, treatment is generally for life.

 
down
 
 
kronek
Composition
Rutin 200 mg
Forskolin 15 mg
Vitamin B1 0,7 mg
Vitamin B2 0,8 mg
 
Description

KRONEK® based on Forskolin, Rutin, Vitamins B1 and B2
- New frontier in glaucoma -

Glaucoma damage is defined as loss of the nerve cells of the retina and their fibres (which constitute the optic nerve) with subsequent defects in the visual field. In the beginning, these defects are not noted by the patient: this is why glaucoma is described as the silent thief of sight.
Today it is common opinion that it is not enough to have eye pressure under control: even in patients undergoing hypotonic treatment, glaucoma progresses and the “thief of sight” continues to cause deterioration of the visual field.

Risk factors for the development of glaucoma, as well as eye pressure, are, as is known, age, race, genetic predisposition, sex and immune defects.
Nevertheless progressive loss of the field of vision is mainly associated, by epidemiological studies, with:

• Circadian pressure fluctuations: it has been demonstrated that patients with great fluctuations in IOP have greater likelihood of suffering damage with progressive functional loss.

• Perfusion of the choroid and optic disc:

These two main risk factors cause the process called apoptosis or programmed cell death in ganglia and nerve cells.
Apoptosis is probably brought on by a reduced axonal flow of information (mechanical theory of compression) and circulatory problems (vascular theory). In this latter case, reperfusion, following a phase of reduced perfusion, leads to the formation of free radicals which also cause an increase in glutamate to toxic levels.

KRONEK® is a dietary supplement based on Coleus forskohlii root extract, Rutin, Vitamin B1 and Vitamin B2. The characteristic ingredient of the root extract of this plant is forskolin, a diterpenoid, the effects of which have all emerged from tests carried out.
The action mechanism of forskolin is mainly ascribed to the property which this plant has of activating an important enzyme, adenyl-cyclase, which leads to an increase on a cellular level of cyclic adenosinmonophosphate (cAMP) and all the functions in which it mediates.
Since cAMP is diminished in numerous disorders, its increase due to forskolin is held to be beneficial in these circumstances.
Adenyl-cyclase has an effect on the control of the production of aqueous humour.
Rutin helps to maintain or repair the physiological functioning of small blood vessels, whilst vitamins B1 and B2, as coenzymes, can help to maintain tissue trophism and, in terms of the nervous system, maintain neurosensorial eye function .

 
Product Use

DOSAGE AND ADMINISTRATION
1 tablet per day, to be swallowed with water in the morning.

PACKAGE
Box: 30 tablets.

 
 
flaguk end